Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone + Venlafaxine in MDD with Insomnia
NCT00435279Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of eszopiclone in major depressive disorder (MDD), sponsored by Sumitomo Pharma America. Started Jun 2007; status: completed.
02
Drugs
eszopiclone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00435279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435279.